Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min

Subjects

Subjects :

2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
medicine.medical_treatment
coronavirus
Urology
Renal function
remdesivir
medicine.disease_cause
Antiviral Agents
medicine
Humans
In patient
Letters
Dialysis
Coronavirus
Pharmacology
Alanine
business.industry
Health Policy
COVID-19
Adenosine Monophosphate
Risk evaluation
AcademicSubjects/MED00410
dialysis
renal
business
Glomerular Filtration Rate

Details

ISSN :

15352900 and 10792082

Database :

OpenAIRE

Journal :

American Journal of Health-System Pharmacy

Accession number :

edsair.doi.dedup.....3d5d8e3ad27341eacf45286277f12095

Full Text :

https://doi.org/10.1093/ajhp/zxab245